Get the latest Science News and Discoveries
World-first study into precision medicine for high-risk childhood cancer yields extraordinary results - EurekAlert
In a world-first, Australian researchers and clinicians have shown that precision medicine leads to significantly improved outcomes in children with high risk cancer. In a study published in Nature Medicine, the researchers found that precision medicine (also called personalized medicine) was shown to be superior to standard or non-guided therapy, both in terms of clinical response and survival - with a staggering 55% of children who received their personalised treatment achieved complete or partial remission, or had their disease stabilised for at least 6 months.
None
Or read this on Eureka Alert